Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Gaw

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Current Opinion in Lipidology|September 12, 2012
Lipid metabolismIan S Young, Allan Gaw
BMJ (Clinical Research Ed.)|February 28, 2004
New European clinical trials directive: implementation requires funding for effective training programmesAllan Gaw, Moira M B Mungall
Current Opinion in Lipidology|July 10, 2004
Statin therapy in the elderlyMoira M B Mungall, Allan Gaw
Cardiovascular Drugs and Therapy|February 18, 2005
The statin breakthrough--remembering to involve the patientAllan Gaw, Elizabeth Tolmie, Grace M Lindsay
Atherosclerosis|May 25, 2005
Plasma lipoprotein(a) [Lp(a)] concentrations and cardiovascular events in the elderly: evidence from the prospective study of pravastatin in the elderly at risk (PROSPER)Allan Gaw, Heather M Murray, E Ann Brown, et al.
Drugs & Aging|March 19, 2003
Statin therapy in the elderly: does it make good clinical and economic sense?Moira M B Mungall, Allan Gaw, James Shepherd
Trials|May 10, 2011
Clinical Trials: Minimising source data queries to streamline endpoint adjudication in a large multi-national trialElizabeth P Tolmie, Eleanor M Dinnett, Elizabeth S Ronald, et al.
Nursing Times|July 18, 2015
Clinical research benefits go viral via TwitterClaire L Gibbs, Abby Greaves, Michael Keeling, et al.
Plos One|September 24, 2013
Are routinely collected NHS administrative records suitable for endpoint identification in clinical trials? Evidence from the West of Scotland Coronary Prevention StudySarah J E Barry, Eleanor Dinnett, Sharon Kean, et al.
Trials|June 14, 2013
Implementing a centralised pharmacovigilance service in a non-commercial setting in the United KingdomEleanor M Dinnett, Sharon Kean, Elizabeth P Tolmie, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Current Opinion in Lipidology|September 12, 2012
Lipid metabolismIan S Young, Allan Gaw
BMJ (Clinical Research Ed.)|February 28, 2004
New European clinical trials directive: implementation requires funding for effective training programmesAllan Gaw, Moira M B Mungall
Current Opinion in Lipidology|July 10, 2004
Statin therapy in the elderlyMoira M B Mungall, Allan Gaw
Cardiovascular Drugs and Therapy|February 18, 2005
The statin breakthrough--remembering to involve the patientAllan Gaw, Elizabeth Tolmie, Grace M Lindsay
Atherosclerosis|May 25, 2005
Plasma lipoprotein(a) [Lp(a)] concentrations and cardiovascular events in the elderly: evidence from the prospective study of pravastatin in the elderly at risk (PROSPER)Allan Gaw, Heather M Murray, E Ann Brown, et al.
Drugs & Aging|March 19, 2003
Statin therapy in the elderly: does it make good clinical and economic sense?Moira M B Mungall, Allan Gaw, James Shepherd
Trials|May 10, 2011
Clinical Trials: Minimising source data queries to streamline endpoint adjudication in a large multi-national trialElizabeth P Tolmie, Eleanor M Dinnett, Elizabeth S Ronald, et al.
Nursing Times|July 18, 2015
Clinical research benefits go viral via TwitterClaire L Gibbs, Abby Greaves, Michael Keeling, et al.
Plos One|September 24, 2013
Are routinely collected NHS administrative records suitable for endpoint identification in clinical trials? Evidence from the West of Scotland Coronary Prevention StudySarah J E Barry, Eleanor Dinnett, Sharon Kean, et al.
Trials|June 14, 2013
Implementing a centralised pharmacovigilance service in a non-commercial setting in the United KingdomEleanor M Dinnett, Sharon Kean, Elizabeth P Tolmie, et al.
Pageof 5